|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_on1272991003 |
| 003 |
OCoLC |
| 005 |
20231120010607.0 |
| 006 |
m o d |
| 007 |
cr un|---aucuu |
| 008 |
211002s2021 cau o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDX
|d OPELS
|d EBLCP
|d OCLCF
|d N$T
|d OCLCO
|d OCLCQ
|d COM
|d UKMGB
|d OCLCQ
|d OCLCO
|
| 015 |
|
|
|a GBC268468
|2 bnb
|
| 016 |
7 |
|
|a 020367512
|2 Uk
|
| 019 |
|
|
|a 1269619004
|a 1272856515
|a 1272957955
|
| 020 |
|
|
|a 0128241802
|
| 020 |
|
|
|a 9780128241806
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128239711
|
| 020 |
|
|
|z 0128239719
|
| 035 |
|
|
|a (OCoLC)1272991003
|z (OCoLC)1269619004
|z (OCoLC)1272856515
|z (OCoLC)1272957955
|
| 050 |
|
4 |
|a RM171.4
|
| 082 |
0 |
4 |
|a 615.39
|
| 245 |
0 |
0 |
|a Nanotechnology for Hematology, Blood Transfusion, and Artificial Blood /
|c edited by Adil Denizli [and more].
|
| 260 |
|
|
|a San Diego :
|b Elsevier,
|c 2021.
|
| 300 |
|
|
|a 1 online resource (495 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Micro and Nano Technologies Ser.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a <P><b>PART 1: FUNDAMENTALS </b>1. Blood-nano interface: an introduction 2. Blood- nanomaterials interactions 3. Immune system -- nanomaterials interactions 4. Uptake by reticuloendothelial system (RES) of the injected nanoparticles 5. Biomimetic nanomedicine: an introduction 6. Transport of nanoparticles in blood flow: Mathematical simulation 7. Effect of nanoparticle on the blood coagulation system (Nanoparticle interface with the blood coagulation system) 8. Toxicity/risk assessment of nanomaterials when used in hematology, blood transfusion and artificial blood</p> <p><b>PART 2: HEMATOLOGY </b>9. Lab-on-a-chip (Lab-on-a-phone) for analysis of blood (diagnosis of blood diseases) 10. Nanotechnology for blood test to predict the blood diseases or blood disorders 11. Nanopharmacology in translational hematology and oncology (Nanotechnology applications in hematological malignancies) 12. Target-specific ligands loaded nanomagnets for blood purification (removal of pathogens without fouling of filter membranes) 13. Nanomaterials- based circulating artificial bioreactor for replacement of blood components 14. Drug delivery systems based on blood cells</p> <p><b>PART 3: BLOOD TRANSFUSION </b>15. Smart blood transfusion: An introduction 16. Nanofiltration 17. Nanotechnology for the preservation of red blood cells 18. Nanotechnology for destroying blood clots</p> <p><b>PART 4: ARTIFICIAL BLOOD </b>19. Artificial red blood cells 20. Platelet substitutes 21. WBC substitutes 22. Future scope</p>
|
| 650 |
|
0 |
|a Blood products.
|
| 650 |
|
0 |
|a Nanotechnology.
|
| 650 |
|
2 |
|a Nanotechnology
|0 (DNLM)D036103
|
| 650 |
|
6 |
|a Produits sanguins.
|0 (CaQQLa)201-0186213
|
| 650 |
|
6 |
|a Nanotechnologie.
|0 (CaQQLa)201-0225435
|
| 650 |
|
7 |
|a Blood products
|2 fast
|0 (OCoLC)fst00834806
|
| 650 |
|
7 |
|a Nanotechnology
|2 fast
|0 (OCoLC)fst01032639
|
| 700 |
1 |
|
|a Denizli, Adil.
|
| 700 |
1 |
|
|a Nguyen, Tu�an Anh.
|
| 700 |
1 |
|
|a Mariappan, Rajan.
|
| 700 |
1 |
|
|a Alam, Mohammad Feroz.
|
| 700 |
1 |
|
|a Rahman, Khaliqur.
|
| 776 |
0 |
8 |
|i Print version:
|a Denizli, Adil.
|t Nanotechnology for Hematology, Blood Transfusion, and Artificial Blood.
|d San Diego : Elsevier, �2021
|z 9780128239711
|
| 830 |
|
0 |
|a Micro & nano technologies.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128239711
|z Texto completo
|
